Who
Fernando Aguirre
Director
Company insider
Files Form 4 as: Director, Synchrony Financial; Director, CVS Health; Director, Aetna Inc /pa/; Chairman, President and CEO, Chiquita Brands International; Director, Coca-Cola Enterprises; Director, Coca Cola Enterprises.
In numbers
- Trades disclosed
- 242
- Buys
- 11
- Sells
- 0
- Bought
- $3.8M
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 20 Apr 2005
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 4 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K846 at $70.97 | filing |
| 17 Aug 2026filed 19 Aug 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,13114 at $80.75 | filing |
| 17 Aug 2026filed 19 Aug 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,13114 at $80.75 | filing |
| 30 Jun 2026filed 2 Jul 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K789 at $76.05 | filing |
| 30 Jun 2026filed 2 Jul 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K789 at $76.05 | filing |
| 21 May 2026filed 22 May 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code D | $146K1,563 at $93.50 | filing |
| 21 May 2026filed 22 May 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code D | $146K1,563 at $93.50 | filing |
| 20 May 2026filed 22 May 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code D | $2.9M30,437 at $93.78 | filing |
| 20 May 2026filed 22 May 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code D | $2.9M30,437 at $93.78 | filing |
| 15 May 2026filed 19 May 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $99914 at $71.38 | filing |
| 15 May 2026filed 19 May 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $99914 at $71.38 | filing |
| 14 May 2026filed 15 May 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $152K1,563 at $97.15 | filing |
| 14 May 2026filed 15 May 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $152K1,563 at $97.15 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K883 at $68.02 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K883 at $68.02 | filing |
| 17 Feb 2026filed 19 Feb 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,01214 at $72.31 | filing |
| 17 Feb 2026filed 19 Feb 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,01214 at $72.31 | filing |
| 31 Dec 2025filed 5 Jan 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $55K660 at $83.43 | filing |
| 31 Dec 2025filed 5 Jan 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $55K660 at $83.43 | filing |
| 20 Nov 2025filed 21 Nov 2025 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $137K1,800 at $76.04 | filing |
News
CVS Health: How To Prepare Your Household for Cold and Flu SeasonCVS · finanznachrichten.de · 21 Oct 2026CVS Health Collaborates With the Midlife Collective To Redefine a Woman's Midlife Health JourneyCVS · finanznachrichten.de · 20 Oct 2026CVS Health: CVS Caremark: Why Transparency Matters in Pharmacy BenefitsCVS · finanznachrichten.de · 19 Oct 2026Synchrony Financial (NYSE:SYF) Stock Price Target Cut by Morgan StanleySYF · tickerreport.com · 14 Oct 2026TD Cowen Cuts Synchrony Financial (NYSE:SYF) Price Target to $86.00SYF · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Fernando Aguirre; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.